Our knowledge clearly show that CK18 is continuously expressed in numerous epithelial cancers, Specially adenocarcinomas. both of those lack of CK18 expression in cancers derived from CK18 beneficial precursor cells and neo-expression in malignancies derived from CK18 positive precursors tend to be linked to unfavorable tumor phenotype and ailment